Drug intelligence / Profile preview

CQR-300

Development stage
Unknown
Lead developer
Gateway Health Alliances
Modality
Small Molecules
Administration
Oral
01

Overview

CQR-300 is a patented, standardized extract of the plant *Cissus quadrangularis*, traditionally used in Indian and African medicine. It is primarily developed as a multifunctional dietary supplement ingredient for weight management, metabolic wellness, and cardiovascular health. Clinical studies have shown that daily administration of 300 mg can significantly reduce body weight, body fat, waist-to-hip ratio, blood pressure (systolic and diastolic), total cholesterol, LDL-cholesterol, triglycerides, fasting blood glucose levels while increasing HDL-cholesterol and serotonin levels in overweight or obese individuals[4][5][6][7][8]. The mechanism of action includes inhibition of digestive enzymes (pancreatic lipase, alpha-amylase, alpha-glucosidase), upregulation of phospho-AMPK activity in adipose tissue (reducing adipogenesis/lipogenesis gene expression), enhancement of GLP-1 secretion and DPP-4 inhibition (potentially improving satiety/appetite control), antioxidant effects via polyphenols/flavonoids/stilbenes content[3][4][10]. It also contains naturally occurring phytosterols as well as vitamins A and C[9]. CQR-300 is not an FDA-approved pharmaceutical but has GRAS status for use as a dietary supplement ingredient.

Brand names
CQR-300CQR300CQR 300
Other names
Cissus quadrangularis extractpatented extract of Cissus quadrangularis
02

Targets

Sucrase-IsomaltaseAMY (Pancreatic alpha-amylase)PNLIP (Pancreatic triacylglycerol lipase)DPP-4 (Dipeptidyl Peptidase-IV)

Beyond the preview

Go deeper on CQR-300.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CQR-300.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call